Company news

Genflow Biosciences PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Genflow Signs CDAs with Animal Health Companies

September 15, 2025

Genflow Biosciences PLC Announces Company Update on Dog Trials

August 18, 2025

Company Update on Dog Trials

August 18, 2025

Genflow Biosciences PLC Announces Clinical Readiness Acceleration

July 24, 2025

Clinical Readiness Acceleration

July 24, 2025

Genflow Confirms Progression of Grant

July 17, 2025

Genflow Biosciences PLC Announces Corporate Update

June 17, 2025

Corporate Update

June 17, 2025

Result of AGM

June 12, 2025

Genflow Signs Master Services Agreement

May 28, 2025

Genflow Biosciences and CER Sign Master Service Agreement to Strengthen Long-Term R&D Collaboration

May 28, 2025

Genflow Biosciences PLC Announces AGM Notice

May 22, 2025

AGM Notice

May 22, 2025

Key SIRT6 Patent Application

May 15, 2025

Genflow Biosciences PLC Announces Key SIRT6 Patent Application

May 15, 2025

Share Subscription, Director's Dealing and Update

May 9, 2025

Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update

May 9, 2025

Genflow Biosciences PLC Announces Final Results

April 30, 2025

Final Results

April 30, 2025

Launch of AI-Powered Partnership

April 14, 2025

Genflow Biosciences PLC Announces Launch of AI-Powered Partnership

April 14, 2025

Genflow Launches New Development Program

April 10, 2025

Genflow Biosciences PLC Launches New Development Program

April 10, 2025

Holding in Company

March 28, 2025

Genflow Biosciences PLC Announces Director Dealings

March 28, 2025

Director Dealings

March 28, 2025

Institutional Investment

March 26, 2025

Genflow Biosciences PLC Announces Institutional Investment

March 26, 2025

Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application

February 20, 2025

Advancements in SIRT6 Variant Patent Application

February 20, 2025

2024 Highlights

January 6, 2025

Genflow Secures Non-Dilutive Financial Support

October 22, 2024

Strengthening of Pre-Clinical Efforts

June 27, 2024

Receipt of Grant Funding

June 12, 2024

Notice of AGM

June 3, 2024

Restoration - GENFLOW BIOSCIENCES PLC

May 8, 2024

Restoration of Listing

May 8, 2024

Full Text of Accounts

May 7, 2024

Temporary Suspension

May 1, 2024

Suspension - GENFLOW BIOSCIENCES PLC

May 1, 2024

Notification of major holdings

April 10, 2024

Genflow Biosciences attracts new institutional investors with £715,000 fundraise

April 8, 2024

Successful Placing and Subscription

April 4, 2024

Publication of a Key European Patent

March 21, 2024

Highlights and Key Priorities

February 1, 2024

Two Non-Dilutive Research Grant Awards

January 18, 2024

Appointment of Joint Broker

November 8, 2023

Company Update

September 20, 2023

Admittance to trading on the OTCQB Venture Market

June 13, 2023

Results of Annual General Meeting

June 8, 2023

← Newer news releases · Older news releases →

Decks